The evolving landscape of brain metastasis: volume II

Brain metastasis (BrM) represents the most common intracranial malignancy, arising in up to 30% of all adult cancer patients and contributing significantly to cancer-related morbidity and mortality. BrM is now recognized as a biologically distinct condition with unique mechanisms of organotropism, colonization, and therapeutic vulnerability. We highlight recent progress in omic and spatial profiling, which has revealed key drivers of brain tropism. These findings have reshaped therapeutic strategies, leading to clinical trials that specifically address central nervous system (CNS) involvement. Emerging approaches now include efforts to prevent brain relapse. Preclinical models increasingly provide sophisticated platforms to evaluate next-generation therapies. Collectively, these advances are transforming the clinical landscape, offering new hope for the prevention and management of BrM through precision medicine and integrated therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Trends in cancer
Published
2025-12-02
DOI
https://doi.org/10.1016/j.trecan.2025.11.007
Citations
1
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The evolving landscape of brain metastasis: volume II

Hussein A. Tawbi, Johanna A. Joyce, Frank Winkler, Carey K. Anders et al.
1 citations
Trends in cancer
Brain Metastases and Treatment
1.52
article

The evolving landscape of brain metastasis: volume II

Hussein A. Tawbi, Johanna A. Joyce, Frank Winkler, Carey K. Anders, Josh Neman, Adrienne Boire, Nuria Kotecki, Srinivas Malladi, Benjamin Izar, Sanne B. Schagen, Joan Massagué, Manuel Valiente, Matthias Preusser, Gelareh Zadeh, Nelson S. Moss, Peter M. Siegel, Varun Venkataramani
article en
1 citations

Abstract

Brain metastasis (BrM) represents the most common intracranial malignancy, arising in up to 30% of all adult cancer patients and contributing significantly to cancer-related morbidity and mortality. BrM is now recognized as a biologically distinct condition with unique mechanisms of organotropism, colonization, and therapeutic vulnerability. We highlight recent progress in omic and spatial profiling, which has revealed key drivers of brain tropism. These findings have reshaped therapeutic strategies, leading to clinical trials that specifically address central nervous system (CNS) involvement. Emerging approaches now include efforts to prevent brain relapse. Preclinical models increasingly provide sophisticated platforms to evaluate next-generation therapies. Collectively, these advances are transforming the clinical landscape, offering new hope for the prevention and management of BrM through precision medicine and integrated therapeutic strategies.

Trends in cancerVol. 12(2)
University of Southern California (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), German Cancer Research Center (DE), Heidelberg University (DE), Columbia University Irving Medical Center (US), Institut Jules Bordet (BE), University Hospital Heidelberg (DE), The Netherlands Cancer Institute (NL), Spanish National Cancer Research Centre (ES), Southwestern Medical Center (US), Ludwig Cancer Research (CH), Mayo Clinic in Florida (US), Neurological Surgery (US), Southwestern Medical Center (US), Duke Cancer Institute, McGill University (CA), Medical University of Vienna (AT), The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 12%
Brain Metastases and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.